Literature DB >> 11284014

Expression of the neural RNA-binding protein Musashi1 in human gliomas.

M Toda1, Y Iizuka, W Yu, T Imai, E Ikeda, K Yoshida, T Kawase, Y Kawakami, H Okano, K Uyemura.   

Abstract

Tumor cells arising from a particular tissue may exhibit the same gene expression patterns as their precursor cells. To test this proposition, we have analyzed the expression of a neural RNA-binding protein, Musashi1, in primary human central nervous system (CNS) tumors. In rodents, Musashi1 is expressed predominantly in proliferating multipotent neural precursor cells, but not in newly generated postmitotic neurons. The expression of Musashi1 is downregulated with the successive progression of neurogenesis. In normal adult human tissues, we detected low levels of Musashi1 expression in brain and testis by RT-PCR analysis. In an RNA panel of 32 cancer tissues and cell lines, elevated expression of Musashi1 was seen in all five malignant gliomas studied, in contrast to the slight expression seen in other tumor cells, including those in several melanomas and a prostate cancer. Western blot analysis showed strong Musashi1 expression in malignant gliomas compared with nonneoplastic brain tissue. Glioblastomas, the most malignant form of glioma, showed higher Musashi1 expression than less malignant gliomas by immunohistochemical analysis. Tumors with strong Musashi1 expression tended to have high proliferative activity. Thus, the expression of Musashi1 correlated with the grade of the malignancy and proliferative activity in gliomas. These results suggest that primary CNS tumors may share gene expression patterns with primitive, undifferentiated CNS cells and that Musashi1 may be a useful marker for the diagnosis of CNS tumors. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284014     DOI: 10.1002/glia.1034

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  82 in total

Review 1.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA.

Authors:  T Imai; A Tokunaga; T Yoshida; M Hashimoto; K Mikoshiba; G Weinmaster; M Nakafuku; H Okano
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation.

Authors:  Karthik Arumugam; Melanie C Macnicol; Angus M Macnicol
Journal:  Mol Reprod Dev       Date:  2012-07-09       Impact factor: 2.609

Review 4.  Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.

Authors:  Melanie C MacNicol; Chad E Cragle; Angus M MacNicol
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

Review 5.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

6.  Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.

Authors:  Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose-Manuel Garcia-Verdugo; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

7.  Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.

Authors:  Lan Lan; Carl Appelman; Amber R Smith; Jia Yu; Sarah Larsen; Rebecca T Marquez; Hao Liu; Xiaoqing Wu; Philip Gao; Anuradha Roy; Asokan Anbanandam; Ragul Gowthaman; John Karanicolas; Roberto N De Guzman; Steven Rogers; Jeffrey Aubé; Min Ji; Robert S Cohen; Kristi L Neufeld; Liang Xu
Journal:  Mol Oncol       Date:  2015-04-10       Impact factor: 6.603

8.  Immunohistochemical study concerning the origin of neurocytoma--a case report.

Authors:  Hirohito Yano; Naoyuki Ohe; Jun Shinoda; Shin-Ichi Yoshimura; Toru Iwama
Journal:  Pathol Oncol Res       Date:  2008-09-18       Impact factor: 3.201

9.  Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.

Authors:  Ming-Hai Wang; Shi-Yong Qin; Shu-Guang Zhang; Guang-Xin Li; Zhen-Hai Yu; Kun Wang; Bin Wang; Mu-Jian Teng; Zhi-Hai Peng
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

10.  Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1.

Authors:  Ubaldo Gioia; Valerio Di Carlo; Pasquale Caramanica; Camilla Toselli; Antonella Cinquino; Marcella Marchioni; Pietro Laneve; Stefano Biagioni; Irene Bozzoni; Emanuele Cacci; Elisa Caffarelli
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.